Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen

Abstract: Although leprosy is a disease with a wide range of clinical manifestations, there is a lack of knowledge about the presence of carriers of Mycobacterium leprae (M leprae), as well as its transmission and the immunological phenomena that cause the onset of the illness. The glycolipid phenol...

Full description

Bibliographic Details
Main Authors: Arocha Francisco, Valero Nereida, Hassanhi Manzur, DeWard Jacobus, Rodríguez Zulay, Maldonado Mery, Espinoza Fabiola, Espina Luz Marina
Format: Article in Journal/Newspaper
Language:English
Spanish
Published: Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales 2006
Subjects:
Online Access:https://doaj.org/article/02681eba352e4de48a05131268995977
id ftdoajarticles:oai:doaj.org/article:02681eba352e4de48a05131268995977
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:02681eba352e4de48a05131268995977 2023-10-01T03:54:24+02:00 Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen Arocha Francisco Valero Nereida Hassanhi Manzur DeWard Jacobus Rodríguez Zulay Maldonado Mery Espinoza Fabiola Espina Luz Marina 2006-12-01T00:00:00Z https://doaj.org/article/02681eba352e4de48a05131268995977 EN ES eng spa Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales https://drive.google.com/file/d/1DcJ9Aky8O6yH3KhGniVfhrqbANPO_0K2/view https://doaj.org/toc/0075-5222 https://doaj.org/toc/2477-9628 0075-5222 2477-9628 https://doaj.org/article/02681eba352e4de48a05131268995977 Kasmera, Vol 34, Iss 2, Pp 102-113 (2006) Leprosy Phenolic Glycolipids–1 antibodies (anti-PGL-1) health center workers physicians and paramedics Hansen’s disease Lepra anti-glicolípido fenólico-1 (anti-PGL-1) personal de centros de salud médicos y paramédicos enfermedad de Hansen Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2006 ftdoajarticles 2023-09-03T00:46:02Z Abstract: Although leprosy is a disease with a wide range of clinical manifestations, there is a lack of knowledge about the presence of carriers of Mycobacterium leprae (M leprae), as well as its transmission and the immunological phenomena that cause the onset of the illness. The glycolipid phenolic-1 antigen (PGL-1) is a M. leprae specific virulence factor, that protects the bacteria against attack by macrophages. Anti PGL-1 antibodies were detected in health center workers (physicians and paramedics) in close contact with leprosy patients to assess their degree of exposition to the bacilli and to determine their usefulness as a risk factor for developing clinical leprosy. Blood samples from 52 leprosy patients contacts and 60 healthy individuals without leprosy patients contact (control group) were collected. The presence of IgM anti-PGL-1 antibodies was determined using the ELISA technique. It was found that 42.3% (22) of the contacts and 5.0% (3) of the healthy individuals without leprosy patient contact were positive for anti PGL-1 antibodies (p <0.05). There were no significant differences related to sex among the studied groups (45.5% vs 41.5%). A higher frequency of sero-positive individuals was found in health centers workers of 36 to 55 years of age, especially medical personnel (73.3%), regardless of years of exposition to the same. A relative risk factor of 1.9 was found in the individuals in close contact with leprosy patients. These results show a higher sero-positive level among health centers workers, especially physicians, which is related to their degree of exposition to the Hansen bacilli. These findings suggest that they have an increased risk of developing clinical leprosy in comparison with the general population. It is recommended that proper basic bio-safety measures be taken as well as follow-up of the sero-positive cases found. Resumen La lepra es una enfermedad con diferentes formas clínicas, sin embargo, es poco el conocimiento que se tiene sobre portadores de Mycobacterium ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
Spanish
topic Leprosy
Phenolic Glycolipids–1 antibodies (anti-PGL-1)
health center workers
physicians and paramedics
Hansen’s disease
Lepra
anti-glicolípido fenólico-1 (anti-PGL-1)
personal de centros de salud
médicos y paramédicos
enfermedad de Hansen
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Leprosy
Phenolic Glycolipids–1 antibodies (anti-PGL-1)
health center workers
physicians and paramedics
Hansen’s disease
Lepra
anti-glicolípido fenólico-1 (anti-PGL-1)
personal de centros de salud
médicos y paramédicos
enfermedad de Hansen
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Arocha Francisco
Valero Nereida
Hassanhi Manzur
DeWard Jacobus
Rodríguez Zulay
Maldonado Mery
Espinoza Fabiola
Espina Luz Marina
Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
topic_facet Leprosy
Phenolic Glycolipids–1 antibodies (anti-PGL-1)
health center workers
physicians and paramedics
Hansen’s disease
Lepra
anti-glicolípido fenólico-1 (anti-PGL-1)
personal de centros de salud
médicos y paramédicos
enfermedad de Hansen
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
description Abstract: Although leprosy is a disease with a wide range of clinical manifestations, there is a lack of knowledge about the presence of carriers of Mycobacterium leprae (M leprae), as well as its transmission and the immunological phenomena that cause the onset of the illness. The glycolipid phenolic-1 antigen (PGL-1) is a M. leprae specific virulence factor, that protects the bacteria against attack by macrophages. Anti PGL-1 antibodies were detected in health center workers (physicians and paramedics) in close contact with leprosy patients to assess their degree of exposition to the bacilli and to determine their usefulness as a risk factor for developing clinical leprosy. Blood samples from 52 leprosy patients contacts and 60 healthy individuals without leprosy patients contact (control group) were collected. The presence of IgM anti-PGL-1 antibodies was determined using the ELISA technique. It was found that 42.3% (22) of the contacts and 5.0% (3) of the healthy individuals without leprosy patient contact were positive for anti PGL-1 antibodies (p <0.05). There were no significant differences related to sex among the studied groups (45.5% vs 41.5%). A higher frequency of sero-positive individuals was found in health centers workers of 36 to 55 years of age, especially medical personnel (73.3%), regardless of years of exposition to the same. A relative risk factor of 1.9 was found in the individuals in close contact with leprosy patients. These results show a higher sero-positive level among health centers workers, especially physicians, which is related to their degree of exposition to the Hansen bacilli. These findings suggest that they have an increased risk of developing clinical leprosy in comparison with the general population. It is recommended that proper basic bio-safety measures be taken as well as follow-up of the sero-positive cases found. Resumen La lepra es una enfermedad con diferentes formas clínicas, sin embargo, es poco el conocimiento que se tiene sobre portadores de Mycobacterium ...
format Article in Journal/Newspaper
author Arocha Francisco
Valero Nereida
Hassanhi Manzur
DeWard Jacobus
Rodríguez Zulay
Maldonado Mery
Espinoza Fabiola
Espina Luz Marina
author_facet Arocha Francisco
Valero Nereida
Hassanhi Manzur
DeWard Jacobus
Rodríguez Zulay
Maldonado Mery
Espinoza Fabiola
Espina Luz Marina
author_sort Arocha Francisco
title Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
title_short Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
title_full Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
title_fullStr Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
title_full_unstemmed Anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de Hansen
title_sort anticuerpos séricos antiglicolípido fenólico 1 en personal de centros de salud en contacto con pacientes con enfermedad de hansen
publisher Universidad del Zulia,Facultad de Medicina,Departamento de Enfermedades Infecciosas y Tropicales
publishDate 2006
url https://doaj.org/article/02681eba352e4de48a05131268995977
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Kasmera, Vol 34, Iss 2, Pp 102-113 (2006)
op_relation https://drive.google.com/file/d/1DcJ9Aky8O6yH3KhGniVfhrqbANPO_0K2/view
https://doaj.org/toc/0075-5222
https://doaj.org/toc/2477-9628
0075-5222
2477-9628
https://doaj.org/article/02681eba352e4de48a05131268995977
_version_ 1778521983719309312